Literature DB >> 12659521

Relocalization of cationic porphyrins during photodynamic therapy.

David Kessel1.   

Abstract

When photodynamic therapy is directed against sub-cellular sites that include mitochondria, the anti-apoptotic protein Bcl-2, lysosomes or the endoplasmic reticulum, there is generally an apoptotic response leading to cell death. We previously reported that the targeting of the plasma membrane by photosensitizing agents led to either a marked delay or inhibition of apoptosis, even if other sub-cellular sites were also targeted for photodamage. Preliminary studies indicated that this result was associated with photodamage to caspase-3, a major element of the 'execution' phase of apoptosis. We describe here a mechanism for apoptosis inhibition resulting from localization of photosensitizers from the membrane to the cytosol during irradiation, leading to selective photodamage of procaspases-9, and -3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12659521     DOI: 10.1039/b206046a

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  15 in total

1.  Death pathways associated with photodynamic therapy.

Authors:  David Kessel
Journal:  Med Laser Appl       Date:  2006-11-15

Review 2.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

4.  Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells.

Authors:  Timothy J Jensen; M Graça H Vicente; Raymond Luguya; Jolanna Norton; Frank R Fronczek; Kevin M Smith
Journal:  J Photochem Photobiol B       Date:  2010-05-23       Impact factor: 6.252

5.  Studies on the subcellular localization of the porphycene CPO.

Authors:  David Kessel; Mary Conley; M Graça H Vicente; John J Reiners
Journal:  Photochem Photobiol       Date:  2005 May-Jun       Impact factor: 3.421

6.  Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy.

Authors:  De-Qun Wu; Ze-Yong Li; Cao Li; Jian-Jun Fan; Bo Lu; Cong Chang; Si-Xue Cheng; Xian-Zheng Zhang; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-11-04       Impact factor: 4.200

7.  An anionic porphyrin binds beta-lactoglobulin A at a superficial site rich in lysine residues.

Authors:  Ivan Silva; Samuel Sansone; Lorenzo Brancaleon
Journal:  Protein J       Date:  2009-01       Impact factor: 2.371

Review 8.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects.

Authors:  K Plaetzer; B Krammer; J Berlanda; F Berr; T Kiesslich
Journal:  Lasers Med Sci       Date:  2008-02-05       Impact factor: 3.161

Review 9.  Photodynamic therapy of cancer. Basic principles and applications.

Authors:  Angeles Juarranz; Pedro Jaén; Francisco Sanz-Rodríguez; Jesús Cuevas; Salvador González
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

10.  Role of ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways.

Authors:  Irena Moserova; Jarmila Kralova
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.